BetaEntity Annotation Prototype

Biomedical literature, made navigable

Follow the entities shaping the evidence.

Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.

Browse by entity family

An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.

View all families
29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed

Popular entities in these results

Choose an entity to see the articles in which it was identified.

Matching articles

29,499 articles · page 138 of 2459
OC-MIBCradical radiotherapyradical cystectomyNACorgan-confined muscle-invasive bladder cancerNeoadjuvant chemotherapyNational Cancer Registry

… radical cystectomy or radical radiotherapy, both after NAC for OC-MIBC. We will use a target trial emulation approach to reduce the ri…

L-arginineLosartan PlusNebivolol PlusAmlodipineHCTZleft ventricular hypertrophyendothelial dysfunctionEssential arterial hypertension (AH)hydrochlorothiazideNebivolol

…dipine combined with hydrochlorothiazide (HCTZ), HCTZ alone, or L-arginine. Blood pressure measurements were conducted using the tail-cuff…

Massachusetts General Hospitalischaemic heart diseaseatrial fibrillationBeth Israel Deaconess Medical Centertype 2 diabetesischaemic strokedilated cardiomyopathyvenous thromboembolismMGHAirwave Health Monitoring Study+6 more

…DMC (n=62K), Airwave Health Monitoring Study (AHMS; n=45K), and Massachusetts General Hospital (MGH; n=1.2M). Contemporaneous echocardiographic, metabolomic, …

mycophenolate mofetiltocilizumabrituximabnintedanibInterstitial lung disease (ILD)systemic sclerosis (SSc)EUSTARSSc-ILDMMF

… (SSc) patients. The recent ERS/EULAR guidelines recommend both mycophenolate mofetil (MMF) and rituximab (RTX) for SSc-ILD and suggest to use a comb…